of future drugs and diagnostic tools. ... The Université de Sherbrooke is a fertile ground for new businesses .... Soft
From Bench to Bedside Expertise and technology converging in a collaborative environment to support the Life Sciences industry!
The Estrie Region: at the Intersection of Business and Research AN INFORMED CHOICE Economic Incentives
Services and Environment
Human Resources and Training
Institut de pharmacologie de Sherbrooke (IPS – Sherbrooke Pharmacology Institute)
• Property tax credits • Financial support • Some of the lowest operating costs in the country
• Support for business start-up and growth • Economic development agencies at your service • A dynamic business community operating in the Health, ICT, and Medical Technology Sectors
• Qualified, specialized labour pool • Largely bilingual labour force • Two universities in the region (French and English) • Co-op programs (internships) • Captive population (clinical trials) • CIUSSS de l’Estrie - CHUS (integrated university health and social services centre)
A preferred partner in Québec for drug discovery and diagnostic research.
Location • Proximity to the U.S. market • Soft-landing program • Affordable lots and buildings available
A culture of multidisciplinary research and the tremendous expertise of its team help IPS develop the products of university research into new drugs and diagnostic tools. Its many partners on the Université de Sherbrooke Health Campus (Faculty of Medicine and Health Sciences, CHUS Research Center) assist IPS in steering projects from the design of new molecules to the validation of new therapeutic and diagnostic
targets, from the preclinical to the clinical stage. As its many active collaborations with the pharmaceutical industry attest (more than 15 companies in 2015), IPS is a key contributor to the development of future drugs and diagnostic tools. usherbrooke.ca/ips
Province of
QUÉBEC Québec
Montréal
ESTRIE Toronto
Canada
Boston
United States United States
Estrie Businesses and Research Platforms at Your Service Industries
Research
The Université de Sherbrooke is a fertile ground for new businesses especially through its many entrepreneurship programs such as ACET (Accélérateur de création d’entreprises technologiques – accelerateur.ca), a technology-business accelerator program, and the opportunity to acquire experience in the field through co-op programs in which training is closely linked to industry. usherbrooke.ca/premier-cycle/stages-coop
The Estrie region can accommodate bench to bedside research, including preclinical and clinical research stages, from the newborn to the elderly.
The Estrie region is the third-largest Life Sciences hub in Québec, home to a host of businesses, both highly specialized and diversified: • • • • • •
Preclinical research Clinical research (phases I-IV) Medical Technologies Healthcare-specific software Drug development And much more!
YOUR BUSINESS HERE! The Estrie region is ready to welcome new collaborations and new businesses to improve the value chain! sherbrooke-innopole.com
The Centre intégré universitaire de santé et de services sociaux – Centre hospitalier universitaire de Sherbrooke (CIUSSS de l’Estrie – CHUS – integrated university health and social services centre) serves some 500,000 residents and includes a University Geriatrics Institute, a Primary Health Care and Social Services University Institute, a University Hospital Centre, an affiliated Rehabilitation Centre, as well as two research centres: Centre de recherche du CHUS (CRCHUS – Research Centre) and Research Centre on Aging (CdRV).
The Université de Sherbrooke includes a Faculty of Medicine and Health Sciences, which is renowned for its 7 centres of excellence in diabetes, obesity and cardiovascular complications; mother and child health; pharmacology and structural biology; RNA biology; inflammation and cancer; molecular imaging; and neuroscience. These centres focus on 5 research themes, which are based on 3 scientific pillars (illustrated below).
CHARLES RIVER: at Home in Estrie! “Our intention was to expand our Montréal operations within the Province of Québec. The site selection process reviewed many assets offered across numerous locations in the Province. Sherbrooke was ultimately selected because of its wealth of expertise in the life sciences domain and most particularly the availability of highly trained technical and scientific talent. Local and regional government efforts also significantly facilitated our transition to Sherbrooke, and we continue to enjoy thriving partnerships within the region.” MICHAEL BROADHURST, SITE DIRECTOR, SHERBROOKE | CHARLES RIVER LABORATORIES: CRIVER.COM
SHERBROOKE.CA/MEDECINE/RECHERCHE/CENTRES-DEXCELLENCE
Electron Microscopy and Histology Research Core Histology and microscopy services ranging from the preparation of human and animal biological samples to their morphological, histological, cellular, and ultrastructural analysis.
RNomics Platform
Medicinal Chemistry Platform
Imeka
Analysis of RNA properties and identification of markers for use in the study of a number of diseases, including cancer.
Synthetic chemistry, medicinal chemistry, radiochemistry, and imaging to design molecular probes in a wide variety of chemical compositions (peptides, carbohydrates, terpenes, chemifluorescents, etc.).
Software for the analysis and visualization of medical images, diffusion MRI, preclinical PET imaging, CT imaging, and tissue analysis for clinical trials.
r n o m i c s-f m s s @ u s h e r b r o o ke . c a 8 1 9 8 2 1 - 8 0 0 0 , e x t . 70 4 5 5 r n o m i c s . m e d . u s h e r b r o o ke . c a
Nathalie Perreault n a t h a l i e . p e r r e a u l t @ u s h e r b r o o ke . c a 8 1 9 8 2 1 - 8 0 0 0, e x t . 7 59 43 u s h e r b r o o ke . c a
Charles River Laboratories Support for every stage in its partners’ research, from drug discovery to marketing, especially preclinical research. Michael Broadhurst m i c h a e l . b r o a d h u r s t @ c r l . co m 8 1 9 3 4 6 -7 5 4 4 c r i ve r. c o m
CONCEPT
DISCOVERY OPTIMIZATION VALIDATION
Proteomics Platform
Preclinical Phenotyping
Mass spectrometry and identification of purified proteins, complex samples, post-translational modifications, etc.
ivPC platform: rodent behavioural assays (pain sensitivity, motor and cognitive functioning, behavioural anomalies, etc.).
Fr a n ço i s- M i c h e l B o i s v e r t f m . b o i s v e r t @ u s h e r b r o o ke . c a 8 1 9 8 2 0 - 6 8 6 8 , e x t . 7 5 43 0 p r o t e o m i q u e . c r c h u l . u l a va l . c a
Louis Gendron l o u i s . g e n d r o n @ u s h e r b r o o ke . c a 8 1 9 8 2 1 - 8 0 0 0 , e x t . 7 2 76 0 u s h e r b r o o ke . c a
Éric Marsault e r i c . m a r s a u l t @ u s h e r b r o o ke . c a 8 1 9 8 2 1 - 8 0 0 0, e x t . 7 243 3 u s h e r b r o o ke . c a/i p s
Imaging Platform Wide range of medical and biomedical imaging modalities for preclinical and clinical studies (PET, MRI, CT, SPECT, etc.). M a r t i n To u s s a i n t m t o u s s a i n t . c h u s @ s s s s . g o u v. q c . c a 8 1 9 3 4 6 -1 1 1 0, e x t . 1 2 8 70 c r. c h u s . q c . c a/e n/s e r v i c e s- o u t i l s/c i m s
Clinical Research Sherbrooke (RCS) A group of four Sherbrooke research centres committed to promoting awareness of the importance of clinical research and its value in the advancement of health research.
Immune Biosolutions
Mass spectrometry services for complex samples (characterization of antibodies and proteins, quantification of peptides, lipids, etc.).
Highly specific validated chicken antibodies for research applications.
Hugo Gagnon
[email protected] 819 238-6284 psbinc.ca
Fr é d é r i c L e d u c f l e d u c @ i b i o s o l u t i o n s . co m 1 8 5 5 3 4 6 -3 4 49 ibiosolutions.com
Processing of images requiring advanced expertise in segmentation, conversion, visualization, parcellation, resetting, and kinetic analysis. PET, MRI, TDM, SPECT, and other techniques. M a r t i n To u s s a i n t m t o u s s a i n t . c h u s @ s s s s . g o u v. q c . c a 8 1 9 3 4 6 -1 1 1 0 , e x t . 1 28 70 c r. c h u s . q c . c a/s e r v i c e s- o u t i l s/p a v i
BioIntelligence Technologies
Neptune Technologies & Bioressources
Real-time intelligent sensors and instruments to increase bioprocess profitability. Applications for industrial, pharmaceutical, and cosmetic biotechnology.
Research, development and scientific validation of nutraceutical products, and commercialization of omega-3 (EPA and DHA) / antioxidant krill oil.
Joël Sirois j s i r o i s @ b i o i n t e l l i g e n ce . co m 1 8 0 0 8 2 0 - 47 8 3 biointelligence.com
M a r i o Tu r co t t e i n f o @ n e p t u n e b i o t e c h . co m 8 1 9 5 6 4 -2 1 1 2 neptunekrilloil.com
CRCHUS Methodological Support Unit for Clinical and Epidemiological Research (URCE)
S u z i e Ta l b o t
[email protected] 8 1 9 3 4 6 -2 8 8 7 diex.ca
Development of software tools fostering collaboration, information sharing, work-process efficiency, etc. Electronic medical records.
Cancer detection and treatment using minimally invasive MRI-guided solutions (percutaneous targeting of prostate lesions).
X av i e r B o i l a r d i n f o @ o m n i m e d . co m 1 8 0 0 5 6 7- 4 8 0 8 omnimed.com
D av i d B o u c h a r d d b o u c h a r d @ p o l y m e r- r o b o t i c s . co m 819 620-8872 p o l y m e r- r o b o t i c s . c o m
Goran Matic g m a t i c @ v i g i l e n t t e l e s y s t e m s . co m 5 1 4 9 0 6 -1 5 43 vigilenttelesystems.com
CLINICAL RESEARCH A private clinical-research company conducting phase I to IV trials (Alzheimer’s, migraines, vaccines, women’s health, obesity, urology, and more).
Polymer Robotics
Complete videoconferencing solutions for a variety of telemedicine applications (remote robotic systems, Vigilent software suite).
M a r t i n To u s s a i n t m t o u s s a i n t . c h u s @ s s s s . g o u v. q c . c a 8 1 9 3 4 6 -1 1 1 0, e x t . 1 2 8 70 c r. c h u s . q c . c a/s e r v i c e s- o u t i l s/p a v i
Diex Recherche
Omnimed
Vigilent Telesystems
Consultation in biostatistics, design, and conduct of clinical and epidemiological studies and data management.
PRECLINICAL RESEARCH
r e c h e r c h e - c l i n i q u e -s h e r b r o o ke . c o m
PhenoSwitch Bioscience
Jean-René Bélanger j r. b e l a n g e r @ i m e k a . c a 1 8 8 8 3 1 1 - 0 59 9 i m e ka . c a
Image Analysis and Visualization Platform (PAVI)
Clinical Research Platform of the Research Centre on Aging (CdRV)
MANUFACTURING Clinical Research Platform of the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS)
Biopharmaceutical clinical research (Alzheimer’s, dementia, sleep, diabetes, dyslipidemia, osteoporosis, sarcopenia, malnutrition) and mining of aging-related Complete clinical research infrastructure (phases I–IV), population and clinical data. with access to populations, expertise, leading-edge M a r i l y n To u s i g n a n t facilities, and services provided by the University m a r i l y n .t o u s i g n a n t @ u s h e r b r o o ke . c a 8 1 9 7 8 0 -2 2 0 , e x t . 4 6 2 1 5 Hospital Centre, including biobanks and databases c d r v. c s s s- i u g s . c a linked to electronic patient records (cardiology, urology, pneumology, endocrinology, oncology, and more).
PATIENT
MARKET
Q&T Research
Lumed
QuadraMed
Evaluative clinical research for the conduct of phase II and III research projects on pharmaceutical products and vaccines (Alzheimer’s, obesity, cardiology, etc.).
Clinical decision support system to streamline the pratice of medecine and improve quality of care (antimicrobial stewardship, prevention and infection control, surveillance, and reporting).
Tools to help healthcare providers improve productivity, ensure regulatory and legal compliance, and enhance the quality of patient care and safety (automatic prescription software, electronic medical records, etc.).
Pierre Ger vais p i e r r e . g e r v a i s @ q t s h e r b r o o ke . co m 8 1 9 5 6 2- 6 3 74 , e x t . 1 28 74 qtresearch.com
V i n ce n t N a u l t
[email protected] 8 1 9 5 74 -247 1 lumed.ca
Guy Bujold g b u j o l d @ q u a d r a m e d . co m 8 1 9 3 47- 8 8 3 3 quadramed.com
St e v e G i r a r d s g i r a r d . c h u s @ s s s s . g o u v. q c . c a 8 1 9 3 4 6 -1 1 1 0 , e x t . 1 28 74 c r. c h u s . q c . c a/r e c h e r c h e - c l i n i q u e
TH I S I S A VO LU NTA RY LI S TI N G O F B U S I N E S S E S A N D P L ATFO R M S . Other products and services are offered in the Estrie region and new projects emerge on a regular basis. For more information, please contact us. I N FO @ S H E R B RO O K E - I N N O P O LE .CO M
Autonomy and Healthy Aging Drug development is one of the major strengths of the Estrie region, closely followed by areas related to maintaining autonomy. Here, autonomy does not relate solely to seniors, but includes anyone affected by an illness or accident who needs medication or technology to improve their quality of life. Interdisciplinary Institute for Technological Innovation (3IT) Infrastructure for scientific innovation and technological maturation, from concept to commercialization, from device to proof of concept and validation, in a range of disciplines (nano- and microtechnologies, biomedical engineering, telecommunications, information systems, robotics, etc.). Proof of concept design for information and communication technologies (ICTs), for validation under actual conditions of use. Exceptional, dynamic, flexible, transversal, translational research and innovation ecosystem, harnessing true university–industry synergy for technological innovation. Fr a n ço i s M i c h a u d f r a n co i s . m i c h a u d @ u s h e r b r o o ke . c a 8 1 9 8 2 0 - 8 0 0 0, e x t . 6 5 701 u s h e r b r o o ke . c a/3 i t
Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS – Research Centre) Associated with the fourth-largest hospital centre in Québec, the CRCHUS is distinctive for its integrated approach, combining fundamental, clinical, epidemiological, and evaluative research. The Centre covers a broad spectrum, from perinatality to end-of-life care, across six research axes: Cancer: Biology, Prognosis and Diagnosis; Diabetes, Obesity, and Cardiovascular Complications; Inflammation and Pain; Medical Imaging; Mother & Child; and Health: Populations, Organization, Practices. W i l l i a m D. Fr a s e r c r c i n f o r m a t i o n . c h u s @ s s s s . g o u v. q c . c a 819 820-6480 c r. c h u s . q c . c a
Research Centre on Aging (CdRV) The CdRV is one of Canada’s largest research centres on aging. Its mission is to produce new knowledge on aging to foster seniors’ autonomy and encourage their development. Aging-related topics, from molecule to society, fall under three research axes: Clinical, Biological Mechanisms of Aging, and Society, Populations, and Services. The CdRV offers several platforms supported by expertise in bioengineering, biostatistics, and biomedical research. The CdRV collaborates with researchers from 7 faculties at the Université de Sherbrooke and from Bishop’s University. Vé r o n i q u e B o u t i e r v e r o n i q u e . b o u t i e r @ u s h e r b r o o ke . c a 8 1 9 7 8 0 -2 2 2 0 , e x t . 45 6 43 c d r v. c s s s- i u g s . c a
Archimed Medical
Ibiom
Customized solutions for therapists and patients (patient slings, frictionless tube slide sheets, walking harnesses, etc.).
Production of ergonomic equipment for use by health-care professionals (stretchers, chairs, etc.).
J e a n - Fr a n ço i s Ta r d i f j f t a r d i f @ a r c h i m e d m e d i c a l . co m 8 1 9 3 47-7 7 7 8 archimedmedical.com
J a s m i n B i b e a u a n d St é p h a n e M o n g e a u i n f o @ i b i o m . co m 45 0 6 7 8 - 5 4 6 8 ibiom.com
Eureka Solutions
Keku Sports
Vehicle adaptation for mobility-challenged clients; modular and portable ramps for residential use.
Equipment designed to enhance the performance and enjoyment of athletes with a disability (high-performance wheelchair ergometer, customized sport seating).
S e r g e L av a l l é e s l av a l l e e @ e u r e k a s o l u t i o n . co m 8 1 9 5 6 2-2 5 5 5 e u r e ka s o l u t i o n . c o m
Physipro Design, production and commercialization of positioning and mobility devices for people with disabilities or reduced autonomy (wheelchairs, seating, etc.). Fa b r y s Fr é c h e t t e f a b r y s .f r e c h e t t e @ p hy s i p r o . co m 8 1 9 5 6 5 -3 3 3 7 physipro.com
Jean-Luc Lessard j e a n l u c . l e s s a r d @ ke k u s p o r t s . co m 8 1 9 3 42-1 0 8 2 ke k u s p o r t s . c o m
Arjohuntleigh Magog Design and production of patient lifts and transfer equipment. Worldwide distribution through a network of sales/service and distribution centres. Anne-Marie Boisse a n n e - m a r i e . b o i s s e @ a r j o h u n t l e i g h . co m 8 1 9 8 6 8 - 0 4 41 , e x t . 3 3 3 8 arjohuntleigh.com
Committed Partners Institut de pharmacologie de Sherbrooke (IPS – Sherbrooke Pharmacology Institute) IPS is dedicated to the study of the actions of drugs and their targets. Work done at the Institute integrates concepts from such disciplines as pharmacology, physiology, chemistry, imaging, and engineering, applying them to the validation of new diagnostic or therapeutic targets, the discovery of new drugs and diagnostic tools, and the development of innovative technologies in these fields. IPS’s primary goals are: • Isolating new molecular and cellular mechanisms driving human pathologies • Discovering new bioactive molecules with the diagnostic or therapeutic potential to act on these mechanisms • Accompanying scientists in the creation of value and industrial collaboration Some of the medical fields in which IPS research is conducted include cardiovascular, respiratory, and inflammatory diseases; cancer; infectious diseases; and pain. Éric Marsault e r i c . m a r s a u l t @ u s h e r b r o o ke . c a 8 1 9 8 2 1 - 8 0 0 0, e x t . 7 243 3 u s h e r b r o o ke . c a/i p s
SAGE-Innovation
Sherbrooke Innopole
SAGE-Innovation is a not-for-profit organization of regional health-care stakeholders, including healthcare, educational and training institutions, community organizations and private-sector companies. It is an umbrella organization for the pooling of ideas and resources through value-added services, projects and activities for its members.
Sherbrooke Innopole is the economic development organization for the City of Sherbrooke. Its mission is to support the City’s economic transition, with an emphasis on innovation and the development of five key sectors, one of which is Life Sciences.
With the ACCORD project (regional development cooperation – Québec’s Ministry of economy, innovation, and export) as its inspiration, SAGE-Innovation is a health, autonomy, and gerontechnology cluster in the Estrie region dedicated to ensuring that the population remains active and independent for as long as possible. Through joint action, its membership aims to enhance quality of life so people can live longer and happier lives through the development of adaptive products and services. SAGE-Innovation is both an economic development initiative centred on supporting overall autonomy and a gerontology hub that pools the strengths and expertise related to this axis. Chantal Michel c m i c h e l . s a g e i n n ov a t i o n @ g m a i l . co m 8 1 9 7 8 0 -2 2 2 0 , e x t . 45 6 1 0 a c c o r d s a n t e e s t r i e .w e e b l y . c o m
Sherbrooke, the central municipality in the Estrie region, is home to a number of companies in the expanding Life Sciences sector. Sherbrooke Innopole offers the following services: • Support for businesses at every stage in their development • Access to investment funds • Access to an international business network • A business mentoring program • Link with regional partners, including an innovative business accelerator/incubator (space and services) Sherbrooke Innopole also offers a soft-landing program for foreign companies interested in exploring the North American market. The program includes support as well as free or discounted space and services. Josée Blanchard j b l a n c h a r d @ s h e r b r o o ke - i n n o p o l e . co m 819 821-557 7 1 87 7 211-5326 s h e r b r o o ke - i n n o p o l e . c o m
